Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
01 1NURAY CHEMICALS PRIVATE LIMITED
02 1Dr. Reddy's Laboratories Limited
03 1Aurobindo Pharma Limited
04 1DARMERICA, LLC
05 1Kyorin Pharmaceutical Group Facility Co., Ltd.
06 1MYLAN LABORATORIES LIMITED
07 1Tianish Laboratories Private Limited
01 1GATIFLOXACIN
02 2GATIFLOXACIN HEMIHYDRATE
03 1Gatifloxacin Anhydrous
04 1Gatifloxacin Hemihydrate
05 2Gatifloxacin Sesquihydrate
01 4India
02 1Japan
03 2U.S.A
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
NDC Package Code : 58159-102
Start Marketing Date : 2024-08-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-040
Start Marketing Date : 2011-09-08
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65862-792
Start Marketing Date : 2023-11-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71052-555
Start Marketing Date : 2019-07-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1000g/1000g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53476-1155
Start Marketing Date : 2018-07-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84206-0051
Start Marketing Date : 2024-08-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-826
Start Marketing Date : 2015-01-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A gatifloxacin anhydrous manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of gatifloxacin anhydrous, including repackagers and relabelers. The FDA regulates gatifloxacin anhydrous manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. gatifloxacin anhydrous API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of gatifloxacin anhydrous manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A gatifloxacin anhydrous supplier is an individual or a company that provides gatifloxacin anhydrous active pharmaceutical ingredient (API) or gatifloxacin anhydrous finished formulations upon request. The gatifloxacin anhydrous suppliers may include gatifloxacin anhydrous API manufacturers, exporters, distributors and traders.
click here to find a list of gatifloxacin anhydrous suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing gatifloxacin anhydrous as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for gatifloxacin anhydrous API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture gatifloxacin anhydrous as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain gatifloxacin anhydrous and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a gatifloxacin anhydrous NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of gatifloxacin anhydrous suppliers with NDC on PharmaCompass.
We have 7 companies offering gatifloxacin anhydrous
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
